SULODEKSID (VESSEL DUE F) - NOVYE PERSPEKTIVY V NEFROPROTEKTIVNOY TERAPII
- Authors: Batyushin M.M1, Galushkin A.A1, Poganeva V.N1, Asrumyan E.G1, Litvinov A.S1, Sadovnichaya N.A1, Tsvetkov D.S1, Rudenko L.I1
-
Affiliations:
- Issue: No 3 (2012)
- Pages: 56-61
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/261737
- ID: 261737
Cite item
Open Access
Access granted
Abstract
Keywords
Full Text
About the authors
M. M Batyushin
Email: nephr-roon@rambler.ru
A. A Galushkin
V. N Poganeva
E. G Asrumyan
A. S Litvinov
N. A Sadovnichaya
D. S Tsvetkov
L. I Rudenko
References
- McCullough P.A., Li S., Jurkovitz C.T. et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am. J. Kidney Dis. 2008; 51 (4 suppl. 2): S38-45.
- National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39(Suppl. 1): Sl—266.
- The Most Expensive Diseases // [электронный ресурс] — 2012. — Режим доступа — www.forbes.com.
- Бикбов Б.Т., Томилина Н. А. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998—2009 гг. (Отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ. 2011; 13(3):150—264
- Zaferani A., Vivès R.R., van der Pol P. et al. Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease. J. Biol. Chem. 2011;286(7):5359—5367.
- Heerspink H.L., Greene T., Lewis J.B. et al. Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria. Nephrol. Dial. Transplant. 2008;23(6):1946—1954.
- Kristovà V., Kriska M., Babâl P. et al. Evaluation of endothelium-protective effects of drugs in experimental models of endothelial damage. Physiol. Res. 2000;49(1):123—128.
- Ciolino H.P., Vijayagopal P., Radhakrishnamurthy B. et al. Heparin stimulates proteoglycan synthesis by vascular smooth muscle cells while suppressing cellular proliferation. Atherosclerosis. 1992;94(2—3):135—146.
- Homma R., Mase A., Toida T. et al. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans. Int. J. Biochem. Cell. Biol. 2005;37(9):1911—1920.
- Gaddi A.V., Cicero A.F., Gambaro G. Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered. Int. J. Nephrol. Renovasc. Dis. 2010;3:99—105.
Supplementary files
